News Headlines

  1. Benefits To UK’s NHS Of Delivering Commercial Contract Research Valued At £383.6M

    The value of clinical research to the NHS, the UK economy and jobs market has been evaluated in a new report, which provides an assessment of the economic impact of the National Institute for Health Research Clinical Research Network’s (NIHR CRN) activities to support clinical research in England.

  2. Enterprise Therapeutics Awarded Up To £5.7M ($7M) From Cystic Fibrosis Foundation

    Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, recently announced it has been awarded up to £5.7M ($7M) funding under the Therapeutics Development Award programme from the Cystic Fibrosis Foundation.

  3. Mogrify Raises Additional $16M To Advance Its Mission To Transform The Development Of Life-Saving Cell Therapies

    Mogrify Ltd (Mogrify), a UK company aiming to transform the development of life-saving cell therapies, recently announced the initial close of its Series A funding. The Company raised $16M USD in this round, bringing the total investment to over $20M USD to date.

  4. Syneos Health Wins Society For Clinical Research Sites Eagle Award For Third Consecutive Year

    Syneos Health, the only fully integrated biopharmaceutical solutions organization, recently announced that the Company was awarded the Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category for a third consecutive year.

  5. Sharp Clinical Officially Opens £9.5M Facility In Rhymney

    Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, officially opened its new £9.5M facility in Rhymney at an Open House and ribbon-cutting ceremony recently.

  6. Veeva Announces Free eRegulatory Solution for Clinical Research Sites

    Veeva SiteVault Free allows sites to manage regulatory documentation and study information for all trials. Veeva aims to help industry accelerate clinical research and streamline study start-up and execution across sites and sponsors

  7. Berg Presents First-In-Kind Data Using Its Bayesian Ai-Driven Interrogative Biology® Technology To Map Underlying Biology Of Patient Responses In Advanced Solid Tumor Trial Of Bpm31510

    Early phase study of BPM31510 demonstrates BERG’s Interrogative Biology® platform can identify the molecular basis of efficacy and adverse events, offering critical insights for drug late-stage development from analyses of longitudinal patient samples


  8. New User Interface Dramatically Speeds Reviews/Approvals For Clinical Trial Disclosure

    TrialScope has released a new version of its TrialScope Disclose™ platform, featuring a revamped user interface (UI). The new functionality is specifically designed to expedite sponsors’ review and approval process for registering and updating clinical trials with regulatory agencies.

  9. Sharp appoints Sascha Sonnenberg as Global Head of Business Development, Sharp Clinical Services

    Sharp, a part of UDG Healthcare and a leading provider of clinical supply services, has strengthened its leadership team with the appointment of Sascha Sonnenberg as global head of business development for Sharp Clinical Supply Services.

  10. PPD To Invest $63M To Expand Bioanalytical Lab In Virginia

    Pharmaceutical Product Development, a leading global contract research organization, will invest $63.7M to expand its bioanalytical lab in Henrico County,Virginia.